Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in Interest ReceivablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Amortizatization of Intangibles (2022 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Amortizatization of Intangibles for 4 consecutive years, with $10605.0 as the latest value for Q3 2025.

  • On a quarterly basis, Amortizatization of Intangibles rose 2.71% to $10605.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $41648.0, a 27.51% decrease, with the full-year FY2024 number at $38502.0, down 23.08% from a year prior.
  • Amortizatization of Intangibles was $10605.0 for Q3 2025 at 60 Degrees Pharmaceuticals, up from $10442.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $29447.0 in Q4 2023 to a low of -$323613.0 in Q3 2022.
  • A 4-year average of -$15505.6 and a median of $9472.0 in 2024 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: skyrocketed 1161.11% in 2023, then crashed 64.35% in 2024.
  • 60 Degrees Pharmaceuticals' Amortizatization of Intangibles stood at $2335.0 in 2022, then surged by 1161.11% to $29447.0 in 2023, then plummeted by 64.35% to $10498.0 in 2024, then grew by 1.02% to $10605.0 in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Amortizatization of Intangibles are $10605.0 (Q3 2025), $10442.0 (Q2 2025), and $10103.0 (Q1 2025).